Interaction of sulfonylurea with the pancreatic B-cell.
D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / Q000494:pharmacology; D005227:Fatty Acids / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology; D005905:Glyburide / Q000378:metabolism; D006801:Humans; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007832:Lasalocid / Q000031:analogs & derivatives / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D009249:NADP / Q000378:metabolism; D010653:Phenylbutazone / Q000494:pharmacology; D012413:Rubidium / Q000378:metabolism; D012709:Serum Albumin / Q000494:pharmacology; D013453:Sulfonylurea Compounds / Q000378:metabolism*; D013997:Time Factors; D014044:Tolbutamide / Q000494:pharmacology
D000596:Amino Acids; D005227:Fatty Acids; D012709:Serum Albumin; D013453:Sulfonylurea Compounds; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; D000001:Calcimycin; D009249:NADP; D000255:Adenosine Triphosphate; D014044:Tolbutamide; D010653:Phenylbutazone; D005947:Glucose; D012413:Rubidium; D005905:Glyburide; D002118:Calcium; C029086:bromolasalocid; D007832:Lasalocid